TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Billionaire Warren Buffett Has $100 Billion to Spend, Maybe on These 8 Companies
STOCKS

Billionaire Warren Buffett Almost Has $100 Billion in Cash to Spend on Buying These 8 Companies

Stocks Struggle for Direction as Economic Improvements May Push Fed Moves
FUTURES

5 things you must know before the market opens Thursday

European Stocks Gain on Mergers, Earnings: FTSE Dip on Unilever Miss
MARKETS

European Stocks Gain on Mergers, Earnings: FTSE Dip on Unilever Miss

Johnson & Johnson to Buy Actelion for $30 Billion, Spin Out R&D Unit
MERGERS AND ACQUISITIONS

Johnson & Johnson to buy Actelion for $30 billion, spin out R&D unit

Actelion Shares Top Swiss Market Despite Opsumit Drug Test Disappointment
INVESTING

Actelion shares top Swiss market despite Opsumit drug test disappointment

Jim Cramer on Why Johnson & Johnson Returned to Actelion Talks
VIDEO

Jim Cramer on Why Johnson & Johnson Returned to Actelion Talks

Johnson & Johnson to Buy Actelion for $30 Billion, Spin Out R&D Unit
MERGERS AND ACQUISITIONS

Actelion's fate may rest on structure, not price, as Clozel holds firm

Best and Worst Closed-End Funds
FUTURES

5 things you must know before the market opens thursday

Jim Cramer's Take on 17 Consumer Stocks if You're Fearing Deflation
MERGERS AND ACQUISITIONS

Actelion hits record high after confirming exclusive talks with Johnson & Johnson

European Stocks Drift Lower in Holiday-Thinned Trading
MARKETS

European stocks drift lower in holiday-thinned trading

Dow Industrials Hit 20,000 for the First Time in History
FUTURES

Dow's steady ascent to 20,000 milestone hits snag

Stocks Sport Slight Losses as Dow's Journey to 20,000 Pauses
FUTURES

Stocks sport slight losses as Dow's journey to 20,000 pauses

Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
MARKETS

Actelion restarts possible merger talks with Johnson & Johnson

Ophthotech Plunges on Eye-Drug-Study Failure
STOCKS

Actelion shares rise amid speculation on possible improved Sanofi bid

Cramer: Top 10 Bull Markets Right Now (Part 2)
FUTURES

5 things you must know before the market opens wednesday

Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
STOCKS

Actelion shares plunge after J&J drops potential $27 billion takeover

European Stocks Fall as Investors Take Cautious Stance Ahead of Fed Meeting
MARKETS

European stocks fall as investors take cautious stance ahead of Fed meeting

5 Things You Must Know Before the Market Opens Tuesday
FUTURES

5 things you must know before the market opens Tuesday

Euro Extends Gains After ECB Minutes Reveal QE Opposition
MARKETS

European stocks slip lower, Italy gains in mixed start to trading

Sanofi, Merck and J&J Tout Lower Drug Prices
STOCKS

Actelion surges on report of Sanofi challenge to J&J takeover bid

Bank Stocks
MARKETS

Dow marches to another record close as S&P 500, Nasdaq also rise

Bank of America, JPMorgan Chase and Other Stellar Banks: 'Mad Money' Lightning Round
MARKETS

Dow sets record high as oil maintains momentum

Stock Futures Hold Lower as Jobless Claims, Import Prices Rise
MARKETS

Dow Hits Record High as Wall Street Shakes Off Italy Vote; Oil Extends Gains

5 Things You Must Know Before the Market Opens Wednesday
MARKETS

Stock futures rise as Wall Street shrugs off Italy referendum defeat; oil gains

5 Things You Must Know Before the Market Opens Monday
FUTURES

5 things you must know before the market opens Monday